Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Galenica AG GALNF OTC

Other OTC • Healthcare • Medical - Distribution • CH • USD

SharesGrow Score
57/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Galenica AG (GALNF) is a Medical - Distribution company in the Healthcare sector, currently trading at $115.00. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Financials: revenue is $4.1B, +1.2%/yr average growth. Net income is $181M, growing at +3.2%/yr. Net profit margin is 4.4% (thin). Gross margin is 10.4% (+1.1 pp trend).

Balance sheet: total debt is $1.1B against $1.5B equity (Debt-to-Equity (D/E) ratio 0.72, moderate). Current ratio is 1.15 (adequate). Debt-to-assets is 31.7%. Total assets: $3.3B.

SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 45/100 (Partial), Past 100/100 (Pass), Health 67/100 (Partial), Moat 42/100 (Fail), Future ?/100 (Fail), Income 30/100 (Fail).

GALNF SharesGrow Score Overview

57/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 60/100
Valuation — P/E, PEG, Forward PEG
GROWTH 45/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 42/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GALNF

✓
VALUE Pass
60/100
GALNF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
45/100
GALNF: +1.2%/yr revenue is, +3.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
GALNF: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet GALNF: Debt-to-Equity (D/E) ratio 0.72 (moderate), Current ratio is 1.15 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
42/100
GALNF: Gross margin is 10.4% (+1.1 pp trend), $6B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 42/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
30/100
GALNF: Net profit margin is 4.4%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range75.25-116.19
Volume800
Avg Volume (30D)6
Market Cap$5.73B
Beta (1Y)0.35
Dividend Yield$2.8652
Share Statistics
EPS (TTM)3.63
Shares Outstanding$49.85M
IPO Date2022-07-11
Employees4,511
CEOMarc Werner
Financial Highlights & Ratios
Revenue (TTM)$4.14B
Gross Profit$429.01M
EBITDA$339.34M
Net Income$181.19M
Operating Income$222.88M
Total Cash$115.56M
Total Debt$1.06B
Net Debt$945.91M
Total Assets$3.35B
Price / Earnings (P/E)31.7
Price / Sales (P/S)1.38
Analyst Forecast
Company Info
CountryCH
ExchangeOther OTC
CurrencyUSD
ISINCH0360674466

Price Chart

Track all markets on TradingView
GALNF
Galenica AG ↗  ·  Other OTC
Healthcare • Medical - Distribution
75.25 52WK RANGE 116.19

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message